AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML.
Sayitoglu EC, Luca BA, Boss AP, Thomas BC, Freeborn RA, Uyeda MJ, Chen PP, Nakauchi Y, Waichler C, Lacayo N, Bacchetta R, Majeti R, Gentles AJ, Cepika AM, Roncarolo MG.
Sayitoglu EC, et al. Among authors: chen pp.
Leukemia. 2024 May 9. doi: 10.1038/s41375-024-02255-1. Online ahead of print.
Leukemia. 2024.
PMID: 38724673